225Ac-PSMA-617

PSMA-617 radiolabeled with Actinium-225 · Endocyte

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 225Ac-PSMA-617, covering 2025-03-21 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 [Phase 1]